1. Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH;
2. Division of Hematology and Oncology, Department of Medicine, Pennsylvania State University College of Medicine, Hershey, PA;
3. Penn State Hershey Cancer Institute, Hershey, PA;
4. Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA;
5. Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA;
6. Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX;
7. Division of Hematology and Oncology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA;
8. University of Virginia Cancer Center, Charlottesville, VA;
9. Nanotechnology Characterization Laboratory, Advanced Technology Program, SAIC-Frederick, Inc., National Cancer Institute–Frederick National Laboratory for Cancer Research, Frederick, MD;
10. Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA;
11. Human Oncology and Pathogenesis Program, Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
12. Pediatric Molecular Oncology Program, Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA; and
13. nanoSTAR Institute, University of Virginia, Charlottesville, VA